Literature DB >> 9862614

The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review.

J Biederman1, E Mick, J Q Bostic, J Prince, J Daly, T E Wilens, T Spencer, J Garcia-Jetton, R Russell, J Wozniak, S V Faraone.   

Abstract

OBJECTIVE: To assess the effectiveness of mood stabilizers in treating maniclike symptoms in children.
METHOD: Subjects were consecutively referred pediatric patients who, at initial intake, satisfied DSM-III-R criteria for mania on a structured diagnostic interview. We systematically reviewed their clinical records to assess (1) the course of maniclike symptoms and (2) all medications prescribed at each follow-up visit. Survival analysis was used to determine the effect of mood stabilizers and other medications on the course of maniclike symptoms.
RESULTS: Of the 59 subjects meeting criteria for mania, 44 (75%) exhibited evidence of maniclike symptoms during follow-up. The occurrence of manic symptoms significantly predicted the subsequent prescription of mood stabilizers (rate ratio = 2.9, 95% confidence interval [CI] = 1.6 to 5.5), and use of mood stabilizers predicted decreases in manic symptoms (rate ratio = 4.9, 95% CI = 1.2 to 20.8). However, improvement was slow and associated with a substantial risk for relapse.
CONCLUSION: Mood stabilizers were frequently used in children with maniclike symptoms, and their use was associated with significant improvement of maniclike symptoms, whereas use of antidepressant, antipsychotic, and stimulant medications was not.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862614     DOI: 10.4088/jcp.v59n1111

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  16 in total

1.  The Subjective Experience of Youth Psychotropic Treatment.

Authors:  Jerry Floersch
Journal:  Soc Work Ment Health       Date:  2004-03-01

Review 2.  Risk of adverse behavioral effects with pediatric use of antidepressants.

Authors:  Wayne K Goodman; Tanya K Murphy; Eric A Storch
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

3.  Misdiagnosis of bipolar disorder.

Authors:  Tanvir Singh; Muhammad Rajput
Journal:  Psychiatry (Edgmont)       Date:  2006-10

Review 4.  Comorbidity in pediatric bipolar disorder.

Authors:  Gagan Joshi; Timothy Wilens
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-04

Review 5.  Pediatric bipolar disease: current and future perspectives for study of its long-term course and treatment.

Authors:  Michael Strober; Boris Birmaher; Neal Ryan; David Axelson; Sylvia Valeri; Henrietta Leonard; Satish Iyengar; Mary Kay Gill; Jeffrey Hunt; Martin Keller
Journal:  Bipolar Disord       Date:  2006-08       Impact factor: 6.744

6.  Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.

Authors:  Rachael M Youngs; Melissa S Chu; Edward G Meloni; Alipi Naydenov; William A Carlezon; Christine Konradi
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

Review 7.  Psychosocial interventions for children with early-onset bipolar spectrum disorder.

Authors:  Nicholas Lofthouse; Mary A Fristad
Journal:  Clin Child Fam Psychol Rev       Date:  2004-06

Review 8.  Omega-3 Supplementation for Psychotic Mania and Comorbid Anxiety in Children.

Authors:  Anthony T Vesco; Jennifer Lehmann; Barbara L Gracious; L Eugene Arnold; Andrea S Young; Mary A Fristad
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-08-19       Impact factor: 2.576

9.  Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic.

Authors:  Mona P Potter; Howard Y Liu; Michael C Monuteaux; Carly S Henderson; Janet Wozniak; Timothy E Wilens; Joseph Biederman
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

10.  The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation.

Authors:  James Waxmonsky; William E Pelham; Elizabeth Gnagy; Michael R Cummings; Briannon O'Connor; Antara Majumdar; Jessica Verley; Martin T Hoffman; Greta A Massetti; Lisa Burrows-MacLean; Gregory A Fabiano; Daniel A Waschbusch; Anil Chacko; Frances W Arnold; Kathryn S Walker; Allison C Garefino; Jessica A Robb
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-12       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.